Cannabis terpenoids enhanced cannabinoid anti-cancer effects, but only when naturally co-occurring in the same strain

Specific terpenoid groups were statistically associated with THC-rich or CBD-rich strains. Only terpenoids naturally co-occurring with a cannabinoid in the same strain enhanced its cytotoxic activity against breast and colon cancer cell lines. This effect was most potent when terpenoids were present in the natural ratios found in cannabis flower.

Analytical profiling (HPLC, GC/MS) of secondary metabolites in 17 cannabis strains. Column separation of compounds. Cell viability assays on MDA-MB-231 (breast cancer) and HCT-116 (colon cancer) cell lines with various cannabinoid-terpenoid combinations.

This provides some of the first scientific evidence for strain-specific entourage effects. It suggests that cannabis breeding has inadvertently selected for cannabinoid-terpenoid combinations that work together, and that mixing terpenoids randomly may not achieve the same synergy.

If the entourage effect is strain-specific rather than universal, it has profound implications for cannabis product design. Simply adding terpenoids to isolates may not replicate the therapeutic effects of whole-plant extracts from specific strains.

In vitro cell line study only. Anti-cancer activity in a dish does not predict clinical efficacy. The mechanism of terpenoid-cannabinoid synergy was not identified. Limited to two cancer cell lines.